TH45445A - The use of a substance similar to GLP-1 and its derivatives GLP-1 through the bloodstream in the modulation of obesity control. - Google Patents

Abstract

DC60 The invention involved the use of glucagon-like peptides such as GLP-1, GLA-1-like peptides, or GLA-1 derivatives in the method and in the mixtures. For body weight reduction, the invention involved the use of glucagon-like peptides such as GLP-1, GLA-1-like peptides, or GLA-1 derivatives in the And in mixtures for weight loss, drug patent

Claims (3)

1. Using a mixture containing peptide-1 similar to ludagon, or similar peptide Together with peptide-1 or its derivatives, it is used as a drug to reduce body weight. 2. The use of mixtures containing peptide-1, galudagon-like, or similar peptides to peptide-1 or their derivatives in the preparation of pharmaceuticals for In treatment Excessive body weight 3. Using a mixture containing Compounds selected from among Contains GLP-1, GLP-1-like peptides or various derivatives of GLP-1 sensory peripheral agents. Tag: drug patent.